HEARING AID RIP-OFF: Brits still paying thousands when hearing aids now on sale for under £130

Millions left struggling as little-known law change slashes cost by up to 95%

Brits are being left in the dark - and in silence - as a little-known law change means non-prescription hearing aids can now be bought for a fraction of the cost of prescription aids. Yet most are still paying thousands through traditional audiology routes.

Last year, UK legislation changed, allowing adults to buy high-quality, ready-to-wear hearing devices directly from retailers as an option to paying for more expensive prescription hearing aids at high street audiology stores.

What once typically cost up to £5,000 can now be available for little more than a weekly shop.

The law change means savings of up to 95% can be made, yet awareness remains shockingly low. It’s a public health scandal and millions are paying the price.

The human cost

Around 18 million adults in the UK suffer from hearing loss or tinnitus. Of those, 2.4 million struggle with everyday conversations. Almost 80% of people over 70 will have some degree of hearing loss, yet vast numbers remain untreated.

Hearing loss doesn't simply stop at struggling to hear the TV. People with untreated hearing loss are twice as likely to suffer mental health problems, according to national hearing loss charity RNID. They can feel isolated and withdraw from social situations.

And the consequences can be devastating: research shows that mild hearing loss doubles the risk of developing dementia, while severe hearing loss makes it five times more likely.

Yet 38% of people who suspect they have a hearing problem haven't even spoken to their GP.* And those who do go through the NHS are often subject to long waiting times and offered devices that don’t always suit their lifestyle or preferences.

The little-known law change

With little fanfare, UK legislation was updated last year to allow adults to be sold devices with both hearing screener and hearing aid software functionalities without a prescription. No audiologist required, no referral, no waiting list.

It's the hearing equivalent of buying non-prescription reading glasses off the shelf. But while reading glasses are now available on every high street, this life-changing legal shift has passed the majority of the British public by entirely.

The result is that millions of people are still stumping up thousands of pounds or even going without because they simply don't know they have another option.

Cheaper options

Now expert companies are filling the gap the law has opened up - and the prices are jaw-dropping.

US hearing tech brand Ceretone has just launched in the UK, bringing ready-to-wear hearing aids starting at just £129.99.

Ceretone’s devices have been awarded with the UK’s Medical Device Regulations (MDR) approval, overseen by government regulators, and widely regarded as the gold standard for ensuring medical devices meet strict safety and performance standards.

The company says it wants to do for hearing what budget glasses retailers did for eyesight: make it accessible for many more people, not just those who can afford private healthcare. They even offer a free hearing screener on their website to allow you to gauge the level of your hearing loss.

Ben Yang, audiology expert at Ceretone, said: “The change in UK law is one of the most significant moments in hearing health in a generation, but it means nothing if people don't know about it. The reality is that millions of Britons are struggling unnecessarily, assuming that proper hearing care is out of their financial reach.

“Our devices are MDR-certified, which means they meet the same rigorous safety and performance standards expected of medical-grade equipment. There is absolutely no reason why high-quality hearing support should cost thousands of pounds. We're here to change that."

Spreading the word

Britain is facing a hearing crisis not because solutions don’t exist, but because people don’t know they do. With affordable, accessible devices now legally available, as an option to more expensive prescription models, it’s time to break the silence and ensure the public finally hears what they’ve been missing.